[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA200600485A1 - Способ получения производных 2-оксо-1-пирролидина - Google Patents

Способ получения производных 2-оксо-1-пирролидина

Info

Publication number
EA200600485A1
EA200600485A1 EA200600485A EA200600485A EA200600485A1 EA 200600485 A1 EA200600485 A1 EA 200600485A1 EA 200600485 A EA200600485 A EA 200600485A EA 200600485 A EA200600485 A EA 200600485A EA 200600485 A1 EA200600485 A1 EA 200600485A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxo
producing
pyrrolidine derivatives
pyrrolidine
derivatives
Prior art date
Application number
EA200600485A
Other languages
English (en)
Other versions
EA010306B1 (ru
Inventor
Джон Суртис
Франсуа Люркен
Усмане Диуф
Original Assignee
Юсб, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юсб, С.А. filed Critical Юсб, С.А.
Publication of EA200600485A1 publication Critical patent/EA200600485A1/ru
Publication of EA010306B1 publication Critical patent/EA010306B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Предложен новый способ получения производных 2-оксо-1-пирролидина общей формулы (I)в которой заместители являются такими, как определено в описании настоящего изобретения.
EA200600485A 2003-09-24 2004-09-13 Способ получения производных 2-оксо-1-пирролидина EA010306B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03021534 2003-09-24
PCT/EP2004/010212 WO2005028435A1 (en) 2003-09-24 2004-09-13 Process for preparing 2-oxo-1-pyrrolidine derivatives

Publications (2)

Publication Number Publication Date
EA200600485A1 true EA200600485A1 (ru) 2007-02-27
EA010306B1 EA010306B1 (ru) 2008-08-29

Family

ID=34354424

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600485A EA010306B1 (ru) 2003-09-24 2004-09-13 Способ получения производных 2-оксо-1-пирролидина

Country Status (15)

Country Link
US (1) US7629474B2 (ru)
EP (1) EP1667967B1 (ru)
JP (1) JP4658937B2 (ru)
KR (1) KR101124098B1 (ru)
CN (1) CN1882535B (ru)
BR (1) BRPI0414436A (ru)
CA (1) CA2538938C (ru)
DK (1) DK1667967T3 (ru)
EA (1) EA010306B1 (ru)
ES (1) ES2390455T3 (ru)
HK (1) HK1094702A1 (ru)
IL (1) IL174029A (ru)
PL (1) PL1667967T3 (ru)
WO (1) WO2005028435A1 (ru)
ZA (1) ZA200601970B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12129228B2 (en) 2019-06-11 2024-10-29 Jilin Asymchem Laboratories Co., Ltd. Continuous synthesis method for 1, 1′-bicyclic [1.1.1]pentane-1,3-diethyl ketone compounds

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194840A1 (en) * 2005-04-01 2008-08-14 Rubamin Laboratories Limited Process for Preparing Levetiracetam and Racemization of (R)- and (S)-2-Amino Butynamide and the Corresponding Acid Derivatives
CA2620243C (en) * 2005-09-15 2015-01-20 Ucb Pharma, S.A. 4-substituted pyrrolidin-2-ones and their use
WO2007065634A1 (en) * 2005-12-07 2007-06-14 Ucb Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
MX2017015133A (es) 2015-05-25 2018-08-01 Suzhou Pengxu Pharmatech Co Ltd Procesos para producir brivaracetam.
WO2017076737A1 (en) 2015-11-03 2017-05-11 Ucb Biopharma Sprl Continuous process for preparing brivaracetam
DK3371150T3 (en) 2015-11-03 2021-11-15 UCB Biopharma SRL Fremgangsmåde til at fremstille brivaracetam
CN105646319B (zh) * 2015-12-30 2018-05-18 佛山市隆信医药科技有限公司 一种布瓦西坦的制备方法
CN107513031B (zh) * 2016-06-16 2022-08-02 上海医药集团股份有限公司 一种2-氧代-1-吡咯烷手性衍生物的制备方法
CN108218757A (zh) * 2016-12-14 2018-06-29 上海医药集团股份有限公司 对2-(4-丙基吡咯烷-2-酮)-丁酰胺非对映异构体的拆分方法
CN106748950B (zh) * 2017-01-13 2019-09-03 成都美域高制药有限公司 一种布瓦西坦及其中间体的制备方法
CN108658831B (zh) * 2017-03-30 2021-11-05 江苏豪森药业集团有限公司 2-氧代-1-吡咯烷衍生物或其盐的制备方法
CN107793342A (zh) * 2017-10-19 2018-03-13 丽珠集团新北江制药股份有限公司 一种布瓦西坦的制备方法
CN108548873A (zh) * 2018-03-20 2018-09-18 丽珠集团新北江制药股份有限公司 一种布瓦西坦中间体异构体的检测方法
CN108929289B (zh) * 2018-06-19 2022-01-04 上海博氏医药科技有限公司 一种用于制备布瓦西坦的中间体化合物及其制备方法和用途
CN110615744B (zh) 2018-06-20 2023-01-06 上海朴颐化学科技有限公司 一种布瓦西坦中间体及其制备方法
CN111333563B (zh) 2018-12-19 2023-11-07 上海科胜药物研发有限公司 一种布瓦西坦中间体的制备方法
CN111892526A (zh) * 2019-05-06 2020-11-06 北京万全德众医药生物技术有限公司 一种布瓦西坦的新制备方法
EP4144724A4 (en) 2020-04-30 2023-03-15 Shanghai Syncores Technologies Inc. Ltd. BRIVARACETAM AND PROCESS FOR MAKING AN INTERMEDIATE THEREOF
WO2023100110A1 (en) 2021-12-02 2023-06-08 Macfarlan Smith Limited Process for preparing brivaracetam

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8827389D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
DE60204224T2 (de) 2001-03-22 2006-02-02 Ucb S.A. Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen
WO2002094787A1 (en) * 2001-05-23 2002-11-28 Ucb, S.A. 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
JP4334344B2 (ja) * 2001-08-10 2009-09-30 ユセベ ファルマ ソシエテ アノニム オキソピロリジン化合物、当該化合物の調製、並びにレベチラセタム及び類似体の製造におけるその化合物の使用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12129228B2 (en) 2019-06-11 2024-10-29 Jilin Asymchem Laboratories Co., Ltd. Continuous synthesis method for 1, 1′-bicyclic [1.1.1]pentane-1,3-diethyl ketone compounds

Also Published As

Publication number Publication date
IL174029A0 (en) 2006-08-01
EA010306B1 (ru) 2008-08-29
EP1667967A1 (en) 2006-06-14
US7629474B2 (en) 2009-12-08
CN1882535A (zh) 2006-12-20
ZA200601970B (en) 2007-05-30
EP1667967B1 (en) 2012-08-01
KR101124098B1 (ko) 2012-03-21
WO2005028435A1 (en) 2005-03-31
IL174029A (en) 2012-06-28
CN1882535B (zh) 2011-05-11
BRPI0414436A (pt) 2006-11-14
AU2004274157A1 (en) 2005-03-31
CA2538938C (en) 2011-08-09
ES2390455T3 (es) 2012-11-13
PL1667967T3 (pl) 2012-11-30
JP2007515387A (ja) 2007-06-14
KR20060121889A (ko) 2006-11-29
US20070100150A1 (en) 2007-05-03
HK1094702A1 (ru) 2007-04-04
DK1667967T3 (da) 2012-10-08
JP4658937B2 (ja) 2011-03-23
CA2538938A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
HK1088597A1 (en) Method for the production of substituted 3-aryl-butyl amine compounds
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
SG158848A1 (en) Method for producing annelated piperazin-2-one derivatives and intermediates of said method
EA200800549A1 (ru) Региоселективный способ получения бензимидазолтиофенов
WO2006021379A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
WO2006021378A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
EA200600197A1 (ru) Получение производных соединения 1,3-дифенилпроп-2-ен-1-он
MXPA05011962A (es) Oxiarenos substituidos.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
PT1893589E (pt) Derivados substituídos de n-benzo[d]isoxazol-3-il-amina como inibidores de recetores mglur5, recetores de serotonina-(5-ht) e recetores de noradrenalina e sua utilização na produção de medicamentos
CY1107101T1 (el) Μεθοδος συνθεσης παραγωγων της 1,3-διϋδρο-2h-3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης με φαρμακευτικως αποδεκτο οξυ
EA200602169A1 (ru) Способ получения производных 2-оксо-1-пирролидина внутримолекулярным аллилированием
DE602006005349D1 (de) Verfahren zur herstellung von hydrazon-derivaten
ATE471312T1 (de) Diaryltriazolmethylamin-derivate sowie ihre herstellung und therapeutische verwendung
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
EA200400876A1 (ru) Способ получения производных толуола
ATE318815T1 (de) Verfahren zur herstellung von enantiomeren von indol-2,3-dion-3-oximderivaten
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
MXPA05011169A (es) Metodo para sintetizar derivados de 5-cloro-1-aril-4 -(4, 5-diciano- 1h-imidazol-2-il)- 3-alquil -1h-pirazola.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment